People
In testimony before the U.S. House Energy and Commerce Subcommittee on Health today, pharmacist-owner Hugh M. Chancy urged support for draft legislation to prohibit restrictive contractual language, often referred to as “gag clauses,” that may result in patients being charged inflated prices for their medications.
Tanja Bosshard Becker joined Executive Insight in 2007 as a consultant.
Appoints Medical Technology Advisory Board to Guide Commercialisation of Sleep Treatment Platform
Biom’up today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director.
Mission Therapeutics today announced the appointment of Dr Judit Molnar, MD, PhD to Senior Director of Translational Medicine with immediate effect.
Probiodrug AG today announced that Dr. Michael Schaeffer has been appointed to the position of Executive Vice President of Business and Strategy, effective August 2018.
Let’s take a look at who made a splash in the pharma and biotech world the past week.
CRISPR pioneer Jennifer Doudna has set up shop in San Francisco’s Gladstone Institutes. Doudna, a UC Berkley professor credited with the co-discovery of CRISPR-Cas9 genome editing technique, will focus on the development of new ways to implement the gene-editing technique for disease treatment.
As part of an earlier announced restructuring program, UK-based GlaxoSmithKline is laying off 650 staffers in the U.S. GlaxoSmithKline employees approximately 15,000 people in the U.S.
Hours after it was reported that Elizabeth Holmes was shutting down Theranos for good, the company’s website has gone dark.
PRESS RELEASES